| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/17/2011 | CN102153640A Anticoagulation protein of tick and gene and application thereof |
| 08/17/2011 | CN102153631A Antimicrobial protein with high-efficiency sterilizing activity and application thereof |
| 08/17/2011 | CN102153630A Ring octapeptide and preparation method and application thereof in medicament making |
| 08/17/2011 | CN102153627A Modifier for gelatinase A inhibitory polypeptide and preparation method thereof |
| 08/17/2011 | CN102153626A Short peptide with bacteriostatic activity and application thereof |
| 08/17/2011 | CN102153625A Dominant epitopes for identification of anti-Titin antibodies and application thereof |
| 08/17/2011 | CN102153623A Compound with thrombolytic activity and preparation method and application thereof |
| 08/17/2011 | CN102153622A Immunopotentiator proline-glycocoll cyclic tetrapeptide (C14H20N404) and application |
| 08/17/2011 | CN102153619A Small molecular weight glycopeptide extracted from stiff silkworm as well as extraction separation method and application thereof |
| 08/17/2011 | CN102151337A Compositions and methods for regulated protein expression in gut |
| 08/17/2011 | CN102151335A Regulation of metabolism by protein lysine acetylation modification |
| 08/17/2011 | CN102151330A Vaccine and method for treatment of motor neurone diseases |
| 08/17/2011 | CN102151329A Antitumor composition and preparation method thereof |
| 08/17/2011 | CN102151289A Method for producing human prothrombin complex |
| 08/17/2011 | CN102151251A Method for freeze-drying reducing glutathione for injection |
| 08/17/2011 | CN102150845A Polysaccharide nutritional product and preparation method and application thereof |
| 08/17/2011 | CN102150654A Additive composition for viscus function protection fluid |
| 08/17/2011 | CN101775401B Rana chensinensis functional gene Rd-RNase3 sequence, construction method and amino acid sequence and application thereof |
| 08/17/2011 | CN101642576B Polyethylene glycol-modified product of KGF-2 and preparation method thereof |
| 08/17/2011 | CN101642572B Protective freezedrying powder of marine microorganism neuzyme and preparation method |
| 08/17/2011 | CN101597288B 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof |
| 08/17/2011 | CN101559216B Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof |
| 08/17/2011 | CN101507712B Sustained-release micro-spheres preparation containing recombined erythropoietin |
| 08/17/2011 | CN101439189B Use of zebra fish Caspy2 gene in preparing medicament for treating tumor |
| 08/17/2011 | CN101422599B Use of scorpion source immunoloregulation polypeptide in preparing medicine for treating rheumatoid arthritis |
| 08/17/2011 | CN101406458B Biodegradable polyester medicine-carrying microsphere of mimetic peroxidase |
| 08/17/2011 | CN101384620B method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 08/17/2011 | CN101302249B Self-assembly short peptide and use thereof in antineoplastic medicine preparation |
| 08/17/2011 | CN101291683B Methods and compositions for treating conditions |
| 08/17/2011 | CN101244072B Application of asiaticoside in pulmonary fibrosis resistant delayed period |
| 08/17/2011 | CN101199484B CTLA4-Ig fusion protein preparation |
| 08/17/2011 | CN101107007B GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/17/2011 | CN101041693B Novel blood sugar lowing polypeptide and uses thereof |
| 08/17/2011 | CN101040616B Pharmaceutical amniotic membrane and processes for their preparation |
| 08/17/2011 | CN101027079B Chimeric protein |
| 08/16/2011 | USRE42624 Methods of using macrocyclic modulators of the ghrelin receptor |
| 08/16/2011 | US7999090 Fungal cell wall synthesis gene |
| 08/16/2011 | US7999076 Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium |
| 08/16/2011 | US7999074 Bacteriocins and novel bacterial strains |
| 08/16/2011 | US7999072 Mutated netrin-4, fragments thereof and their use as medicines |
| 08/16/2011 | US7999071 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine |
| 08/16/2011 | US7999070 Process for screening of a binding peptide specific for specific RNA and RNA binding peptides therefrom |
| 08/16/2011 | US7999069 EphB receptor-binding peptides |
| 08/16/2011 | US7999067 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998934 PAI-2 conjugates for the treatment and imaging of cancer |
| 08/16/2011 | US7998933 Process for treating the skin comprising applying to the skin at least one composition comprising at least one N-aminoacylamide |
| 08/16/2011 | US7998932 inhibition of angiogenesis or apoptosis and treating tumor with an antitumor biodrug |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998930 Modified growth hormones |
| 08/16/2011 | US7998929 A G-CSF solution formulation which is substantially free from proteins as a stabilizer but which contains at least one amino acid or a salt thereof as a stabilizer. |
| 08/16/2011 | US7998928 Method of treatment of type-1 diabetes with a humanin analogue |
| 08/16/2011 | US7998927 For reducing aggregation or immunogenicity of peptide or polypeptide including an alkylglycoside, especially dodecyl maltoside, tridecyl maltoside, sucrose monododecanoate, sucrose monotridecanoate, or sucrose monotetradecanoate; treatment of obesity |
| 08/16/2011 | US7998926 Dimerized T-cell receptor fragment, its compositions and use |
| 08/16/2011 | US7998924 Compounds that bind to p185 and methods of using the same |
| 08/16/2011 | US7998923 quantum dots surface attached with a bioactivation peptide having surface recognition part that is bound to the surface of such particle and and one or more functional parts attached to amino-end or a carboxy-end of molecular recognition part; hydrophobic spacer and binding clustures; bioconjugation |
| 08/16/2011 | US7998740 Cytokine induction of selectin ligands on cells |
| 08/16/2011 | US7998738 Integrin-binding antibodies |
| 08/16/2011 | US7998734 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders |
| 08/16/2011 | US7998718 Identification and functional characterization of a novel ribosomal S6 protein kinase |
| 08/16/2011 | US7998701 Molecule |
| 08/16/2011 | US7998685 Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity |
| 08/16/2011 | US7998680 Determining genotype of a polymorphic site in the hereditary hemochromatosis gene |
| 08/16/2011 | US7998507 Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors |
| 08/16/2011 | US7998502 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 08/16/2011 | US7998492 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 08/16/2011 | US7998491 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 08/16/2011 | US7998490 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
| 08/16/2011 | US7998486 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
| 08/16/2011 | US7998483 Lage-1 tumor associated nucleic acids |
| 08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
| 08/16/2011 | US7998476 Method of treatment using Aspergillus oryzae protease |
| 08/16/2011 | US7998469 Modified interferon beta for use in treatment and prevention of autoimmune, nervous system, cell proliferative, liver, blood and infcetious disorders; directed protein design |
| 08/16/2011 | US7998468 Cytokine zalpha11 ligand antibodies |
| 08/16/2011 | US7998460 Prevention of deficits in neurogenesis with anti-inflammatory agents |
| 08/16/2011 | CA2587061C Deamidated interferon-beta |
| 08/16/2011 | CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 08/16/2011 | CA2487095C Elongase genes and uses thereof |
| 08/16/2011 | CA2472880C Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours |
| 08/16/2011 | CA2439598C Modified derivatives of cck-8 |
| 08/16/2011 | CA2412730C Method for preparing a physiologically active il-18 polypeptide |
| 08/16/2011 | CA2405450C Dermacentor variabilis gaba-gated chloride channels |
| 08/16/2011 | CA2401624C Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/16/2011 | CA2397590C Antisense inhibition of ptp1b expression |
| 08/16/2011 | CA2389979C Methods of inhibiting metastasis |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2376164C Intermolecularly associating compounds, and aggregates comprising them |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/16/2011 | CA2321837C Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 08/16/2011 | CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 08/11/2011 | WO2011097596A2 Methods of using agents that modulate claudin expression |
| 08/11/2011 | WO2011097581A2 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
| 08/11/2011 | WO2011097573A2 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells |
| 08/11/2011 | WO2011097571A2 Methods for the use of progestogen as a glucocorticoid sensitizer |
| 08/11/2011 | WO2011097533A1 Chlorotoxin polypeptides and conjugates and uses thereof |
| 08/11/2011 | WO2011097401A1 Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides |
| 08/11/2011 | WO2011097388A1 Selective inhibition of polyglutamine protein expression |
| 08/11/2011 | WO2011097381A2 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof |
| 08/11/2011 | WO2011097335A2 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof |
| 08/11/2011 | WO2011097266A1 Use of proteases for gluten intolerance |